Biomaterials are specifically engineered to support tissue, nerve and muscle regeneration across the body, yet physicians and ...

On Thursday, the FDA granted full approval to Humacyte, Inc.’s (NASDAQ:HUMA) Symvess (acellular tissue-engineered vessel-tyod) use in adults as a vascular conduit for extremity arterial injury when ...

As the field of bioengineering continues to advance, scientists are making significant strides in growing organs for transplants. Among the most promising developments is the growth of lungs in the ...